Zobrazeno 1 - 3
of 3
pro vyhledávání: '"R. Matt Liley"'
Autor:
Daniel Stone, Kelly R. Long, Michelle A. Loprieno, Harshana S. De Silva Feelixge, Elizabeth J. Kenkel, R. Matt Liley, Stephen Rapp, Pavitra Roychoudhury, Thuy Nguyen, Laurence Stensland, Rossana Colón-Thillet, Lindsay M. Klouser, Nicholas D. Weber, Connie Le, Jessica Wagoner, Erin A. Goecker, Alvason Zhenhua Li, Karsten Eichholz, Lawrence Corey, D. Lorne Tyrrell, Alexander L. Greninger, Meei-Li Huang, Stephen J. Polyak, Martine Aubert, John E. Sagartz, Keith R. Jerome
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss , Pp 258-275 (2021)
Chronic hepatitis B virus (HBV) infection is a major public health problem. New treatment approaches are needed because current treatments do not target covalently closed circular DNA (cccDNA), the template for HBV replication, and rarely clear the v
Externí odkaz:
https://doaj.org/article/50136f1751074d8594ac5811c80e88ea
Autor:
Jessica Wagoner, Elizabeth J. Kenkel, Daniel Stone, Nicholas D. Weber, R. Matt Liley, Lindsay M. Klouser, Martine Aubert, Stephen J. Polyak, Keith R. Jerome, Connie Le, John E. Sagartz, Pavitra Roychoudhury, Stephen R. Rapp, Lawrence Corey, Erin A. Goecker, Rossana Colón-Thillet, Thuy Nguyen, Kelly R. Long, Michelle A. Loprieno, D. Lorne Tyrrell, Alexander L. Greninger, Laurence Stensland, Meei-Li Huang, Harshana S. De Silva Feelixge, Karsten Eichholz, Alvason Zhenhua Li
Publikováno v:
Molecular Therapy. Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss, Pp 258-275 (2021)
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss, Pp 258-275 (2021)
Chronic hepatitis B virus (HBV) infection is a major public health problem. New treatment approaches are needed because current treatments do not target covalently closed circular DNA (cccDNA), the template for HBV replication, and rarely clear the v
Autor:
R. Mark L. Buller, Nathan L. Ponzar, Juan A. Villa, Lisa Wilson, R. Matt Liley, John E. Sagartz, Elena Lomonosova, Ryan P. Murelli, Kelly R. Long, John E. Tavis, John Bial, Qilan Li, Alexandre Grigoryan, Stephen R. Rapp, Erin Touchette
Chronic hepatitis B virus infection cannot be cured by current therapies, so new treatments are urgently needed. We recently identified novel inhibitors of the hepatitis B virus ribonuclease H that suppress viral replication in cell culture. Here, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b46be5b091682b241b92f80dc87b2c5
https://europepmc.org/articles/PMC5743599/
https://europepmc.org/articles/PMC5743599/